Browsing by Subject "Rivastigmine"
Now showing items 1-3 of 3
-
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
(Brac University, 2022-10-30)Rivastigmine is an anti-cholinesterase agent, used to treat mild to moderate dementia of Alzheimer’s disease (AD). Its efficacy and tolerability increase the treatment compliance. This study focused on determining the ... -
A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
(Brac University, 2023-10)The study employed the Food and Drug Administration Adverse Event Reporting System (FAERS) database to study the impact of Rivastigmine, an acetylcholinesterase inhibitor (AChI), on patient mortality. The study determines ... -
Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
(Brac University, 2023-02)The following study utilized the Food and Drug Administration Adverse Event Reporting System (FAERS) database to determine the AChI inhibitor, rivastigmine’s effect on patient mortality as well as its side effect of ...
